Articles

10 ‘enhanced value’ stocks of companies expected to grow quickly through 2026

A narrowly focused screen of value stocks highlights stocks trading cheaply to book value, sales and earnings, but which are also expected to increase sales per share rapidly

This lawn mower maker’s stock tumbles as customers showed ‘increased caution’

Toro’s stock tanked Thursday, after the lawn mower maker reported fiscal third-quarter earnings that missed expectations and lowered its full-year outlook, citing slowing demand from homeowners and dealers.

From first to worst — this government report just saw a massive downgrade

The quality of government statistics seems to be declining around the world — but even set against diminishing standards, Ireland just produced a downgrade of seismic proportions.

Economy grew again in August, ISM finds, but momentum faded

The service side of the economy grew again in August, but momentum faded in response to higher interest rates, slower sales and less customer traffic, a new ISM survey found.

Want to watch every NFL game this season? It’s going to cost you nearly $2,500.

Watching all NFL games this season will require a big financial commitment, seven streaming services and six username-and-password combinations

Land’s End stock rises on narrower loss, revenue beat

Clothing brand marks sixth straight quarter of gross margin growth

Mexican peso falls below key level. How a strong currency turned weak in a hurry

Economic concerns and fears about constitutional upheaval also power peso sell-off

Britain opens investigation into Oasis tickets

Britain’s competition regulator on Thursday announced an investigation into Ticketmaster sales of Oasis tickets, after fans complained about the difficulty of securing tickets to the rock band’s new tour.

Conservative cable TV brand Newsmax plans to go public

Newsmax Inc. said Thursday it plans to launch an initial public offering later this year or early in 2025 following to raise about $75 million, after a private placement for accredited investors.

Eli Lilly’s weekly insulin intensifies race with Novo Nordisk

A pair of late-stage trials found that Eli Lilly’s experimental once-weekly insulin can lower blood sugar as effectively as widely used daily insulins, the drugmaker said Thursday, intensifying the company’s race with Novo Nordisk to develop longer-acting insulins.

Jobless claims drop to 8-week low. Hiring has slowed, but layoffs aren’t rising.

The number of Americans who applied for unemployment benefits last week fell slightly to 227,000 and touched a 8-week low, reinforcing the view that companies are reluctant to lay off workers even as they clamp down on new hiring.

U.S. productivity in the second quarter was better than initial estimates

Output per hour up 2.5% versus prior estimate of
1 1,031 1,032 1,033 1,034 1,035 2,541